For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat ...

The deal – which has a total value of up to $1.3 billion including an unspecified upfront payment – gives Bayer exclusive ...

Big money has been spent on bolstering attacking departments this summer; Man Utd, Liverpool, Arsenal and Chelsea have been among the highest spenders; Sky Sports Laura Hunter assesses which signings ...

Latest Chelsea news as Trevoh Chalobah comes off with an injury during the pre-season friendly against AC Milan at Stamford ...

German pharmaceutical giant Bayer said Tuesday it had struck a deal valued at up to $1.3 billion (1.1 billion euros) with a US-based biotech company to develop its prospective cancer drug.

Poku joins Leverkusen on a long-term contract from Eredivisie side AZ Alkmaar, where he came through the youth ranks.

Ernest Poku has officially joined Bayer 04 Leverkusen from Dutch side AZ.The 21-year-old winger has inked a five-year deal ...

UEFA Champions League winners Paris Saint-Germain face Europa League Tottenham in European football’s curtain raiser.

Ernest Poku is moving to Bayer Leverkusen and has signed a contract with Erik ten Hag’s team until mid-2030. The 21-year-old ...

Bayer Leverkusen sporting director Simon Rolfes said of the club’s new acquisition: “Ernest is an excellent winger who, with ...

Nicolas Jackson has made his preferred destination clear to Chelsea. The Senegalese striker wants to leave Stamford Bridge ...

Bayer (BAYZF) on Tuesday unveiled a partnership deal worth up to $1.3 billion with Kumquat Biosciences to develop the U.S.-based oncology specialist's potential new cancer drug.